Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02464228
Title Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma
Acronym PTCL
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kura Oncology, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Stanford University Medical Center Palo Alto California 94305 United States Details
Yale University, Yale Cancer Center New Haven Connecticut 06520 United States Details
H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa Florida 33612 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Samsung Medical Center Seoul 06351 Korea, Republic of Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
Institut Catala d'Oncologia de Girona Girona 17007 Spain Details
MD Anderson Cancer Center Madrid Madrid 28033 Spain Details
Hospital Universitario 12 Octubre de Madrid Madrid 28041 Spain Details
Hospital Universitario de Salamanca Salamanca 37007 Spain Details
Hospital Universitario Virgen del Rocio Sevilla 41013 Spain Details
Hospital Clinico Universitario de Valencia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field